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Oxidative Stress Via Hydrogen Peroxide Affects
Proopiomelanocortin Peptides Directly in the
Epidermis of Patients with Vitiligo
Jennifer D. Spencer1, Nicholas C.J. Gibbons1,2,3, Hartmut Rokos1,2,3, Eva M.J. Peters4, John M. Wood1,2,3 and
Karin U. Schallreuter1,2,3
The human skin holds the capacity for autocrine processing of the proopiomelanocortin (POMC)-derived
peptides. Recent data demonstrated the presence and functionality of ACTH, a- and b-melanocyte-stimulating
hormone (MSH), and b-endorphin in the regulation of skin pigmentation, and a role has been put forward for
a-MSH as an effective antioxidant. In patients with vitiligo, decreased epidermal POMC processing and low
a-MSH levels were documented previously. These patients accumulate hydrogen peroxide (H2O2) in the 10
3
M
range in their epidermis. Therefore, we examined the involvement of H2O2 on POMC-derived peptides as
possible targets for oxidation by this reactive oxygen species. To address this, we employed immunofluores-
cence labelling, dot blot analysis, Fourier transform Raman spectroscopy, functionality studies, and computer
simulation of the peptide structures. We demonstrate H2O2-mediated oxidation of epidermal ACTH, a-MSH,
and b-endorphin in vitiligo owing to oxidation of methionine residues in the sequences of these peptides.
Moreover, we show that oxidized b-endorphin loses its function in the promotion of pigmentation in
melanocytes. These changes are reversible upon the reduction of H2O2 levels by a pseudocatalase PC-KUS.
Moreover, oxidation of a-MSH can be prevented by the formation of a 1:1 complex with the abundant cofactor
(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin. Thus, using vitiligo, we demonstrate that H2O2 can affect pigment-
ation via epidermal POMC peptide redox homeostasis.
Journal of Investigative Dermatology (2007) 127, 411–420. doi:10.1038/sj.jid.5700538; published online 31 August 2006
INTRODUCTION
It is now well established that the proopiomelanocortin
(POMC)-processing machinery is present in human skin
(Slominski and Wortsman, 2000). The involvement of POMC-
derived peptides such as ACTH, a-, and b-melanocyte-
stimulating hormone (MSH) in human skin pigmentation was
first recognized upon systemic application into human
volunteers, where these peptides induced noticeable skin
darkening especially in the sun-exposed body region (Lerner
and McGuire, 1961, 1964; Geschwind et al., 1972). Today,
there is compelling evidence that POMC-derived peptides are
implicated in the regulation of skin color in humans
(Wakamatsu et al., 1997; Slominski et al., 2004). It has been
shown that the skin and the hair follicle are local sources and
targets for POMC-derived peptides including ACTH, a-, and
b-MSH as well as b-endorphin (Wakamatsu et al., 1997;
Thody and Graham, 1998; Kauser et al., 2003; Spencer et al.,
2005). Only recently, it was recognized that b-endorphin can
also induce pigmentation and proliferation via the m-opiate
receptor of epidermal and hair follicle melanocytes and that
this peptide modulates cell dendricity (Kauser et al., 2003,
2005). Earlier, it was shown that b-MSH stimulates changes in
melanocyte morphology, growth rates, and melanin produc-
tion (McLane and Pawelek, 1988; Chakraborty et al., 1991).
Moreover, the presence of ACTH, a-, b-MSH, and b-endor-
phin together with the complete POMC-processing machinery,
including prohormone convertases 1/2 (PC1 and PC2) and the
regulatory protein 7B2, has been demonstrated inside the
melanosome of epidermal and hair follicle melanocytes (Peters
et al., 2000; Kauser et al., 2003; Spencer et al., 2005). In this
context, a receptor-independent regulation of tyrosinase (EC
1.14.18.1), the key enzyme for pigmentation, by a- and b-MSH
via the cofactor (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin
(6BH4) and its 7-isomer has been put forward (Schallreuter
et al., 1999a; Peters et al., 2000; Spencer et al., 2005).
Besides the function to regulate pigmentation vis a vis
POMC-derived peptides, a wide range of pleiotropic func-
tions for a-MSH has been discovered and documented in the
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skin including the modulation of inflammatory stimuli such
as regulation of expression and secretion of chemokines,
downregulation of proinflammatory signal-induced NF-kB
activation and adhesion molecule expression, prostaglandin
E2 synthesis, as well as induction of IL-10 (reviewed by Luger
et al., 1999). In dermal fibroblasts, a-MSH modulates
collagen metabolism by upregulating interstitial collagenase
as well as by attenuating the inductive effect of transforming
growth factor-b1 on collagen synthesis and fibrosis (Graham
et al., 1999; Thody, 1999; Bohm and Luger, 2004). Moreover,
an antioxidant capacity was proposed and demonstrated for
a-MSH by several investigators (Valverde et al., 1996;
Haycock et al., 2000; Moustafa et al., 2002).
Previously, reduced POMC processing has been reported
in the epidermis of patients with the pigmentation disorder
vitiligo (Graham et al., 1999). To date, there are several lines
of in vivo and in vitro evidence for the accumulation of
hydrogen peroxide (H2O2) in the 10
3
M range in the
epidermal compartment of acute vitiligo (Schallreuter et al.,
1999b, 2001), and therefore it was suggested that the reduced
expression of a-MSH as well as the PC1 and PC2 in vitiligo
epidermis possibly contributes to an impaired antioxidant
defense capacity in this disorder (Graham et al., 1999). The
accumulation of H2O2 leads to a plethora of events including
oxidation of methionine (Met) and tryptophan (Trp) residues
in epidermal enzyme and protein structures; for instance,
catalase (Maresca et al., 2006), dihydropteridine reductase
(Hasse et al., 2004), acetylcholinesterase (Schallreuter et al.,
2004), pterin 4a-carbinolamine dehydratase (Schallreuter
et al., 2001), and albumin (Rokos et al., 2004; Hasse et al.,
2005) as well as oxidation of the essential cofactor 6BH4 in
both melanocytes and keratinocytes (Moore et al., 2002;
Rokos et al., 2002). The latter pathway and the cofactor itself
are greatly affected by H2O2-mediated oxidation in vitiligo
(Schallreuter et al., 1994; Schallreuter, 2005).
Taken together, this disease provides an excellent model
to follow the influence of oxidative stress in vivo and in vitro.
As Met and/or Trp residues in the sequence of POMC-derived
peptides are possible targets for H2O2 oxidation, it was
tempting to ask the question whether these amino acids are
indeed oxidized in these peptides by this reactive oxygen
species. In order to address this question, we employed
different techniques including in situ immunofluorescence
labelling and image analysis, dot blot analysis, Fourier
transform (FT)-Raman spectroscopy, functional studies, and
computer simulation of the peptide structures. The immuno-
reactivity of the in situ study confirmed a significantly lower
expression of a-MSH in untreated vitiligo as reported earlier
by Graham et al. (1999). In addition, a significantly reduced
expression was also observed for b-endorphin, whereas
b-MSH and ACTH expression was higher. After removal of
epidermal H2O2 by a narrowband-activated pseudocatalase
PC-KUS (Schallreuter et al., 1999b), both a-MSH and
b-endorphin expression returned to normal. The direct effect
of H2O2 on the peptides revealed b-endorphin as the most
sensitive peptide followed by a-MSH and ACTH, whereas
b-MSH was only affected by extremely high concentrations
of this reactive oxygen species. These findings were in
agreement with the formation of Met sulfoxide from Met as
shown by FT-Raman spectroscopy and computer simulation
in the presence of H2O2. Oxidation of the peptides also
affected the functionality because oxidized b-endorphin
could not promote melanogenesis in primary human
melanocytes compared to the native peptide. In addition,
we provide evidence that complexation of 6BH4 to a-MSH in
a 1:1 stoichiometry protects both a-MSH and the cofactor
against oxidation by H2O2, offering a novel mechanistic basis
for the proposed antioxidant property of a-MSH.
Our results demonstrate that epidermal POMC peptides
can be directly targeted by H2O2 in vitro but also in vivo as
shown in the skin of patients with vitiligo. This oxidation
affects the peptide structure and consequently their function-
ality. However, these changes are reversible after reduction
of H2O2 levels by a pseudocatalase PC-KUS. Based on these
results, we propose an important role for H2O2 in control of
the redox balance of POMC peptides and consequently their
downstream signals including pigmentation.
RESULTS
Decreased epidermal a-MSH and b-endorphin peptide
expression in vitiligo recovers after H2O2 removal with
pseudocatalase PC-KUS
Earlier, it was shown that a-MSH, PC1, PC2, and 7B2
expression was decreased in the epidermis of patients with
vitiligo, but a mechanism for this loss escaped definition so
far (Graham et al., 1999). As the sequences of all peptides as
well as the PCs contain Met and/or Trp residues and these
amino acids can be targets for oxidation by H2O2 as shown
recently by us and others, it was tempting to investigate
whether epidermal POMC peptide expression was possibly
affected by H2O2. For this purpose, we evaluated the
immunoreactivity of ACTH, a-, b-MSH, and b-endorphin in
skin biopsies of untreated and treated patients in situ
compared with healthy controls. The immunoreactivity was
subject to image analysis as described in the Materials and
Methods section.
The results showed indeed that both epidermal a-MSH and
b-endorphin peptide expression is significantly reduced in
untreated patients with active disease compared to healthy
controls (Figure 1a, b, e, and f). After removal/reduction of
epidermal H2O2 with narrowband-activated pseudocatalase
PC-KUS, peptide expression was significantly higher com-
pared to controls (Figure 1a, c, e, and g). As accumulation of
H2O2 in the 10
3
M range had already been demonstrated
earlier by in vivo FT-Raman spectroscopy (Schallreuter et al.,
1999b), and this process is reversible after reduction of H2O2
levels below 103 M concentrations with a pseudocatalase
PC-KUS (Schallreuter, 1999), these in situ results strongly
suggested that H2O2 alters the structure yielding to a loss of
antigenic epitope recognition of both POMC peptides.
Interestingly, epidermal b-MSH expression appeared to be
unaffected by H2O2. Figure 1i, k, and q–t shows a small
increase, although significant compared to control skin after
reduction of epidermal H2O2 (Po0.005). Expression of
ACTH is significantly increased in situ compared to controls
(Figure 1m–o and q–t) and peptide expression is even higher
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following removal of epidermal H2O2. This result suggests
that PC1 must be more active in vitiligo to produce ACTH.
H2O2 alters the structure of ACTH, a-MSH, and b-endorphin
but not b-MSH
The structures of all peptides studied highlighting the position
of H2O2-sensitive Met residues are presented in Table 1. In
order to examine the structural stability of ACTH, a-, b-MSH,
and b-endorphin to direct oxidation by H2O2, we employed
dot blot analysis in the absence and presence of increasing
H2O2 concentrations as outlined in Materials and Methods.
The results showed that b-endorphin is the most sensitive
peptide to H2O2 oxidation followed by a-MSH and ACTH,
whereas b-MSH is significantly more stable under the same
experimental conditions. (Figure 2a–d).
H2O2-oxidized b-endorphin looses its function in the promotion
of melanogenesis
As structural alteration could be a prerequisite for the lack
of epitope recognition by the antibodies, we tested the
functionality of b-endorphin as one representative peptide
following induction of melanogenesis in primary human
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Figure 1. In situ expression of POMC peptides in healthy controls and in patients with vitiligo. Epidermal expression of the POMC peptides (a–d) a-MSH
and (e–h) b-endorphin, (i–l) b-MSH, and (m–p) ACTH, is decreased in active patients with vitiligo compared to healthy controls. After reduction/removal of
epidermal H2O2 by a narrowband UVB-activated pseudocatalase PC-KUS, the peptides recover (a, e, i, m) healthy control, (b, f, j, n) untreated skin, (c, g, k, o)
treated repigmenting skin, (d, h, l, p) antibody neutralization with blocking peptide, and (q–t) image analysis of staining intensities. Bar¼100 mM. Note the
strong expression of b-endorphin in basal melanocytes (e, g).
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epidermal melanocytes in the presence of the oxidized and
native peptide. The result of this experiment is presented in
Figure 3, showing that b-endorphin after oxidation with
103 M H2O2 cannot induce melanogenesis compared to the
native peptide. Therefore, we can conclude that oxidation of
the peptide severely affects downstream signalling.
a-MSH/6BH4 1:1 complexation protects both the peptide and
the cofactor against H2O2-mediated oxidation
Taking into consideration that a-MSH has antioxidant proper-
ties (Valverde et al., 1996; Haycock et al., 2000; Moustafa
et al., 2002), and that the results of this study show that this
peptide is sensitive to direct oxidation by H2O2 (Figure 2a),
Table 1. The position of Met and Trp residues in the
primary sequences of POMC-derived peptides as
potential targets for H2O2 oxidation
ACTH
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-
Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-
Phe-Pro-Leu-Glu-Phe
a-MSH
N-acetyl-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
b-MSH
Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-
Ser-Pro-Pro-Lys-Asp
b-Endorphin
N-acetyl-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-
Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr
H2O2, hydrogen peroxide; Met, methionine; MSH, melanocyte-stimulat-
ing hormone; POMC, proopiomelanocortin; Trp, tryptophan.
Met and Trp residues are shown in bold.
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Figure 2. The direct effect of H2O2 on POMC peptides. Dot blot analysis in the absence and presence of H2O2 (0–100103 M). (a) a-MSH, (b) b-endorphin,
(c) b-MSH, and (d) ACTH. The result indicates structural alteration with a possible loss of antigenic epitope of a-MSH, b-endorphin, and ACTH with
increasing H2O2 concentrations, whereas b-MSH is much more stable to oxidation. Data shown are mean7SEM (n¼ 3).
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Figure 3. H2O2-oxidized b-endorphin stops the induction of pigmentation
in melanocytes in vitro. Addition of native b-endorphin (108 M) shows
a statistically significant increase of melanin formation compared to the
untreated control cells (***Po0.001). After oxidation of b-endorphin with
103 M H2O2, this effect is significantly abrogated proving that the oxidation
of the peptide affects the function/downstream signal of the native peptide
(*Po0.05). Melanin production is standardized to 1 mg of melanocyte
protein. Results are presented as the mean of three determinations7SEM.
(ns P40.05)
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we asked the question, how can a-MSH exert antioxidant
properties if it is sensitive to H2O2 oxidation itself? In this
context, it was reconciled that a-MSH reacts with the cofactor
6BH4 by forming a 1:1 complex and that this complex can
protect 6BH4 against H2O2 oxidation (Moore et al., 1999;
Schallreuter et al., 1999a). Based on those earlier observa-
tions, it was tempting to explore whether the a-MSH/6BH4
1:1 complex could possibly also protect a-MSH from
oxidation by H2O2. The results of this study proved that
a-MSH is indeed protected against H2O2 oxidation up to
concentrations of 5 103 M, whereas a-MSH alone is
oxidized (Figure 4). Based on these results, we can conclude
that the complex is an efficient scavenger for H2O2.
FT-Raman spectroscopy confirms oxidation of Met to Met
sulfoxide in ACTH, a-, b-MSH, and b-endorphin
As all four peptide hormones contain a single Met residue in
their sequence (Figure 5) and this residue is a sensitive target
of H2O2 oxidation, we employed FT-Raman spectroscopy to
follow the oxidation of the Met residues to Met sulfoxide. The
result of this analysis proved the oxidation of Met by H2O2 in
all four peptides yielding the expected S¼O-stretch at
1026 cm1. The correct assignment was confirmed using a
Met sulfoxide standard (Figure 5).
Computer simulation supports structural alteration by H2O2-
mediated oxidation for ACTH and b-endorphin, whereas b-MSH
is only weakly affected
As it has been established in vivo that epidermal H2O2
accumulation in patients with vitiligo reaches concentrations
in the 103 M range (Schallreuter et al., 1999b; Schallreuter,
2005) and these concentrations are sufficient to oxidize Met
and Trp residues to Met sulfoxide and to 5-OH-Trp,
respectively (Schallreuter et al., 2001; Hasse et al., 2004;
Schallreuter et al., 2004; Schallreuter, 2006; Wood, 2006), we
employed HyperchemTM software to ascertain structural
changes for the melanocortins ACTH, b-MSH, and b-endo-
rphin before and after oxidation of Met and Trp residues with
H2O2. Unfortunately, the structure of a-MSH in solution in
crystals and upon association with phospholipids reveals that
secondary structural features (e.g. a helices and b-pleated
sheets) only occur when a-MSH associates with phospho-
lipids (Biaggi et al., 1996, 1997; Contreras et al., 2001).
Therefore, it was concluded that a-MSH has no secondary
structure in solution (Admiraal and Vos, 1984; Biaggi et al.,
1996, 1997; Prabhu et al., 1999). Using HyperchemTM, we
were unable to find any defined structure for a-MSH.
Therefore, we examined its structure in water using Circular
Dichroism, Intrinsic Fluorescence of Trp, and Isothermal
Calorimetry. These methods confirmed that a-MSH is a
random structure in solution (Pey et al., 2006, unpublished
results). The structural changes of the other peptides after
H2O2 exposure and the structures of the native peptides were
superimposed and are presented in Figure 6a–c. As shown in
Table 1, ACTH and b-MSH have single Met and Trp residues
in their sequence, whereas b-endorphin contains only one Met
residue. Computer simulation supports a significantly altered
structure in the case of ACTH and b-endorphin, whereas the
b-MSH structure is only slightly affected after H2O2 oxidation.
The latter result is in agreement with the in situ results (Figure
1e–h and i–l) and dot blot analyses (Figure 2b and c), favoring a
possible loss of the antigenic epitope. However, despite the
computer and dot blot analyses indicate instability for ACTH
to H2O2, we found increased in situ peptide expression (Figure
1m–p). As pointed out above, this result may suggest that the
processing of ACTH by PC1 could be altered.
DISCUSSION
Vitiligo is a depigmentation disorder characterized by the
sudden loss of inherited skin color. The cause of the disease is
still unknown. One dogma is that the pigment-forming
melanocyte is completely absent in affected areas (Le Poole
et al., 1993). However, there is evidence that even in long-
lasting disease melanocytes are still present but these cells
have lost their integrity and functionality (Tobin et al., 2000).
This loss is associated with severe epidermal oxidative stress
caused by the continuous accumulation of H2O2 up to
concentrations in 103 M range as shown in vivo (Schallreuter
et al., 1999b; Schallreuter, 2005). One consequence of this
H2O2-mediated stress is the oxidation and deactivation of
several important enzymes and proteins in the epidermal
compartment of these patients owing to oxidation of Met and
Trp residues in their sequences causing pronounced structur-
al changes (Schallreuter et al., 2001, 2004; Hasse et al.,
2004; Maresca et al., 2006). Structural analysis of POMC-
derived peptides revealed the presence of Met and Trp
residues as potential targets for H2O2-mediated oxidation.
Moreover, an earlier study by Graham et al. (1999) showed
that a-MSH expression was decreased in the epidermis and in
melanocytes of patients with vitiligo. Therefore, we investi-
gated the fate of ACTH, a-, b-MSH, and b-endorphin
expression in situ in these patients before and after
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reduction/removal of epidermal H2O2 with a narrowband
UVB-activated pseudocatalase PC-KUS (Schallreuter et al.,
1999b). Moreover, we followed the direct susceptibility of
these melanocortins to H2O2-mediated oxidation. The results
revealed that b-endorphin and a-MSH but not ACTH and
b-MSH show a significantly reduced expression in patients
with untreated vitiligo compared to controls. Moreover, we
showed that the most sensitive peptide b-endorphin lost its
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functionality after oxidation by 103 M H2O2 (Figure 3). These
in situ results were supported by H2O2 oxidation/stability
studies, where sensitivities are b-endorphin4a-MSH
4ACTH4b-MSH. The structural simulation study on
b-MSH implies that this peptide is not an easy target to
oxidation owing to the position of Met and Trp in the
sequence, whereas Met in b-endorphin is very exposed.
a-MSH also contains its Met residue in a very exposed
position. However, owing to its small size, it is not possible to
study the effect of H2O2 on its structure in solution by
computer simulation (Prabhu et al., 1999). Although native
ACTH is susceptible to oxidative damage owing to the
position of both Met and Trp residues, the in situ results do
not show a loss of this peptide (Figure 1d). It could be
possible that the significant increase of ACTH compared to
controls is based on low PC2 levels in these patients as
reported previously (Graham et al., 1999), or on increased
PC1 activity. As this PC is coupled to the regulatory protein
7B2, it would be most tempting to follow the effect of H2O2
on both PCs as well as the regulatory protein. Unfortunately
at this time, we do not have access to native enzymes and to
the regulatory protein, although computer simulation sug-
gests that this processing machinery is structurally affected
(data not shown). As ACTH, a-, b-MSH, and b-endorphin
have been implicated in melanocyte growth, dendricity, and
pigmentation and these peptides, except b-MSH can be
directly affected by H2O2 stress, our results support these
peptides as major players in the loss of melanocyte integrity
and function in vitiligo. Moreover, these results suggest a role
for H2O2 in the regulation of POMC peptide processing as a
general mechanism.
The results of the study presented herein also demon-
strated that a-MSH alone has very low antioxidant properties
per se, whereas the a-MSH/6BH4 1:1 complex is an efficient
antioxidant against H2O2 where 6BH4 protects a-MSH and
vice versa supporting a close symbiotic relationship between
hormone and cofactor. These novel results are supported by
an earlier study by Moore et al. (1999), who showed the
protection of 6BH4 oxidation by a-MSH. As the cofactor
6BH4 is present in concentrations of 10
6
M in epidermal cells
as well as in many other cells, this mechanism could be
important in general for protection of a-MSH (Schallreuter
et al., 1994). None of the other POMC peptides have this
capacity, because of the lack of the specific binding domain
for 6BH4. As the human epidermis holds the capacity for Met
sulfoxide repair, it is expected that the oxidation of Met
residues in POMC-derived peptides are reversible in normal
healthy skin (Ogawa et al., 2006; Schallreuter, 2006).
However, preliminary results from our laboratory indicate
that this repair mechanism can also be affected in untreated
active vitiligo (data not shown). Future work is underway to
elucidate this outcome in more detail.
In summary, we show for the first time that the melanocortins
with the exception of b-MSH are directly subjected to oxidative
damage by H2O2 as shown in the skin of patients with vitiligo
and by direct exposure of the peptides to this reactive oxygen
species. This oxidation can severely affect also the functionality/
downstream signal. Importantly, oxidation of a-MSH can be
prevented by a-MSH/6BH4 1:1 complexation, which in turn
identified a novel effective antioxidant mechanism.
MATERIALS AND METHODS
Human tissue samples
Full skin was obtained under local anesthesia from sun-unexposed
sites of each donor as 3-mm punch biopsies from healthy donors
Met II/MetSO II
Met 5/MetSO 5
MetSO 4
5-OH Trp 9
 Trp 9
 Met 4
Trp 16/5-OH Trp 16
c
b
a
Figure 6. Comparison of computer-simulated native and H2O2-oxidized
POMC peptide structures. (a) b-MSH. Met11 and Trp16 of native b-MSH are
shown in green, MetSO11 and 5-OH-Trp16 of H2O2-oxidized b-MSH are
shown in orange. N.B. The structural changes are very small after oxidation of
the Met and Trp residues in this POMC peptide (native peptide in yellow,
oxidized in light blue). (b) b-Endorphin. Met5 of native b-endorphin is shown
in green, MetSO5 of H2O2-oxidized b-endorphin is shown in orange. This
oxidation yields a significant change in the secondary structure of the peptide
(native peptide in yellow, oxidized in light blue). (c) ACTH. Met4 and Trp9 of
native ACTH are shown in green, MetSO4 and 5-OH-Trp9 of H2O2 oxidized
ACTH are shown in orange. Oxidation of those residues leads to major
changes in the secondary structure in this peptide (native peptide in yellow,
oxidized in light blue).
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(n¼ 6) and from patients with vitiligo before (n¼ 9) and after (n¼ 9)
treatment with narrowband UVB-activated pseudocatalase PC-KUS
(Schallreuter et al., 1999b). Patients were otherwise healthy. All
probands had skin phototype III, Fitzpatrick classification (Fitzpatrick
et al., 1967), and were age matched. Biopsies from the patients were
taken from the center of untreated lesional skin and from
repigmenting skin. This study was conducted after signed consent
of each participant in accordance with the guidelines in the
Declaration of Helsinki Principles and was approved by the local
Ethics Committees.
Human melanocyte cell cultures
Epidermal melanocytes (passage 3) established from normal
healthy skin (skin phototype III, Fitzpatrick classification), obtained
with informed consent after elective plastic surgery, were seeded
at a density of 1 105 cells per T-25 cell culture flask (Corning
Costar Corporation, Cambridge, MA) in a commercially available
M254 media (Cascade Biologics Inc., Nottinghamshire, UK)
and allowed to attach overnight. Cells were subsequently grown
without fetal bovine serum or 12-O-tetradecanoylphorbol-
13-acetate for 48 hours before stimulation for 72 hours with
b-endorphin (Sigma, Poole, Dorset, UK), 108 M, with or without
prior exposure to 1 mM H2O2 (Sigma, Poole, Dorset, UK) for
45 minutes. Any excess H2O2 was removed by the addition of 5 ml
catalase (40 mM) (Sigma, Poole, Dorset, UK). As a negative control,
melanocytes from the same donor were grown in the absence of the
peptide.
Determination of melanin concentration
For the measurement of melanin content, the cells were trypsinized
and pelleted by centrifugation (1,000 r.p.m., 41C, 5 minutes) and
solubilized in 0.5 ml 1 N sodium hydroxide, followed by boiling for
1 hour. Melanin content was measured spectrophotometrically at
475 nm using a standard curve of synthetic melanin (Sigma, Poole,
Dorset, UK) 5–50 mg/ml. The results were correlated to the protein
content of each sample using the Bradford assay (BioRad Labo-
ratories, Hercules, CA).
In situ immunofluorescence labelling of POMC peptides
Biopsies were mounted using optical coherence tomography-
embedding medium (Raymond A. Lamb, Eastbourne, East Sussex,
UK) and cryosections, (5 mm) were cut onto poly-L-lysine- (Sigma,
Poole, Dorset, UK) coated slides and were air-dried at room
temperature followed by fixation in ice-cold acetone for 10 minutes
at 201C. Slides were rehydrated in phosphate-buffered saline (PBS)
for 5 minutes and blocked with 10% normal donkey serum (Serotec,
Oxford, UK), diluted in PBS for 90 minutes at room temperature, and
washed with 4 PBS. Next, the slides were incubated for 2–3 hours
at room temperature with the primary antibodies diluted in 1%
normal donkey serum in PBS against a-MSH (ICN Pharmaceuticals
Inc., Aurora, IL; dilution 1:50), b-MSH (Bachem Ltd, St Helens,
Merseyside, UK; dilution 1:200), b-endorphin (Bachem Ltd, St
Helens, Merseyside, UK; dilution 1:10), and ACTH (Abcam Ltd,
Cambridge, UK; dilution 1:400) followed by a wash for 20 minutes
in 4 PBS containing 0.05% Tween 20TM. In order to visualize the
specific antigen, an FITC-conjugated donkey secondary antibody
(Jackson Immunoresearch Laboratories Europe, Soham, Cambridge-
shire, UK, anti-mouse for b-endorphin and anti-rabbit for all others)
was added to the sections at a 1:100 dilution in 1% normal donkey
serum in PBS and incubated for 1 hour at room temperature. After a
final wash of 4 PBS and once in 0.05% Tween 20TM in PBS, the
slides were mounted in Vectashield mounting medium containing
40,6-diamidino-2-phenylindole (Vector Laboratories Ltd, Peterbor-
ough, UK). For negative controls the primary antibody was omitted
and for specific blocking, the antibodies were pre-incubated with a
5-fold excess of the respective peptide for 2 hours at room
temperature before use.
Sections were viewed with a Leica DMIRB/E fluorescence
microscope (Wetzlar, Germany) and photo-documented using a
digital CCD Camera, C8484-05G (Hamamatsu Photonics UK Ltd,
Welwyn Garden City, Herts, UK) and the IPLab for windows imaging
software, version 3.6.4 (Scanalytics Inc., Fairfax, VA).
Image analysis
Image analysis was utilized to assess staining intensities for both the
immunofluorescence labelling and the dot blot technique using the
IPLab for windows imaging software (as above).
Dot blot analysis
The manual spotting method used in this study followed the protocol
recommended by the manufacturers of polyvinylidene difluoride
membranes (Immobillon-P, Millipore, Bedford, UK). Briefly, 1 ml of
each sample was applied onto a pre-wetted polyvinylidene
difluoride membrane, allowing the samples to be absorbed. The
peptides were applied in concentrations of 0.45, 0.4, 0.44, and
0.38mg/ml of ACTH (Bachem Ltd, St Helens, Merseyside, UK;
dilution 1:10), a-MSH (Bachem Ltd, St Helens, Merseyside, UK),
b-MSH (Bachem Ltd, St Helens, Merseyside, UK), and b-endorphin
(Sigma, Poole, Dorset, UK), respectively, following incubation for
2 hours with different concentrations of H2O2 (0–100 103 M). The
membrane was air dried before blocking with 3% BSA (Sigma,
Poole, Dorset, UK) in Tris-buffered saline-T buffer (20 mM Tris-
buffered saline with 0.047% TweenTM at pH 7.4) overnight at 41C
followed by a wash of 4 10 minutes with Tris-buffered saline-T
buffer. Next, the membrane was incubated with the primary
antibodies diluted in 1% BSA in PBS for 2 hours at room temperature
in the case of ACTH (Abcam Ltd, Cambridge, UK; 1:5,000), a-MSH
(ICN Pharmaceuticals Inc., Aurora, IL; dilution 1:1,000), and b-MSH
(Bachem Ltd, St Helens, Merseyside, UK; dilution 1:2,000),
whereas b-endorphin (Bachem Ltd, St Helens, Merseyside, UK;
dilution of 1:100) was incubated overnight at room temperature.
This step was followed by a wash of 4 10 minutes in Tris-buffered
saline-T buffer and a further incubation for 1 hour at room
temperature with a horseradish peroxidase-conjugated secondary
antibody (Sigma, Poole, Dorset, UK, anti-mouse for b-endorphin
and anti-rabbit for all others). Following a final wash, visuali-
zation of the ‘‘dots’’ was performed using modified enhanced
chemiluminescence fixed on a film sheet (X-OMAT, Kodak,
London, UK).
As it was shown earlier that a-MSH protects 6BH4 against
oxidation by H2O2 (Moore et al., 1999), we decided to follow the
possible antioxidant property of the 1:1 a-MSH/6BH4 complex
compared to a-MSH alone. For this purpose, we pre-incubated the
peptide and 6BH4 together for 15 minutes before incubating the
peptide/6BH4 complex for 2 hours with H2O2 following the same
procedure as described above.
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FT-Raman spectroscopy for detection of Met sulfoxide in
H2O2-oxidized POMC peptides
FT-Raman spectra were acquired using a Bruker RFS 100/S spectro-
meter (Bruker, Karlsruhe, Germany) with a liquid-nitrogen-cooled
Germanium detector. Near-infrared excitation was produced by a
Nd3þ :YAG laser operating at 1064 nm. Each spectrum was
accumulated over 17 minutes with 1000 scans and a resolution of
4 cm1. All peptide samples were lyophilized after oxidation with
H2O2 (100 103 M) and measured as solids. The S¼O-stretch was
visualized as a peak at 1026 cm1. The assignment was confirmed
with a solid Met sulfoxide standard (Sigma, Dorset, Poole, UK). The
second peak detected in the standard was assigned to impurity
owing to Met sulfone. This product was confirmed by amino-acid
analysis (Hasse et al., 2004).
Molecular structural computer modelling of ACTH, b-MSH, and
b-endorphin
Structural studies of the native and H2O2-oxidized Met and Trp
residues in the POMC peptides ACTH, b-MSH, and b-endorphin
were constructed using HyperchemTM software (Gainsville, FL) to
model the secondary structure minimized in water.
Statistical analysis
For statistical analysis of epidermal peptide expression the unpaired
t-test (2-tail) was employed. Statistical analysis of the functional
study with b-endorphin was carried out with the one-tailed paired
t-test.
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